efficacy of psychological interventions on depression anxiety and … · 2020. 11. 23. · acarturk...
TRANSCRIPT
Vol:.(1234567890)
Journal of Immigrant and Minority Health (2020) 22:1320–1346https://doi.org/10.1007/s10903-020-01055-w
1 3
REVIEW PAPER
Efficacy of Psychological Interventions on Depression Anxiety and Somatization in Migrants: A Meta‑analysis
Daniela Sambucini1 · Paola Aceto2,3 · Edvaldo Begotaraj1 · Carlo Lai1
Published online: 25 July 2020 © The Author(s) 2020
AbstractMany studies reveal the effectiveness of different psychological interventions on the adult refugees reporting mental health distress. Aim of this metanalysis was to test the efficacy of different psychological treatments on the depressive, anxiety and somatization symptoms on refugees and asylum seekers. Fifty-two studies, since 1997 to 2019, were included in the sys-tematic review and 27 of those were included in the metanalysis. Studies providing a pre and post treatment methodological design were included. All treatments reported significant effects on the three outcomes. Qualitative observations showed a probability to have a significant pre-post treatment effects on trials with outcome of depression (56%), anxiety (44%), and somatization (42%). Cognitive behavioral treatment resulted the most effective treatment. The status of refugee compared to the status of asylum seeker seems to have a great effect on the effectiveness of the treatment.
Keywords Migration · Psychological intervention · Depression · Anxiety · Somatization
Introduction
Geopolitical migration caused the emergency to individuate an efficacy intervention for treating the traumatic symptoma-tology of the migrants [1]. The migrants often originate from countries with governate conditions of war or great poorness that increase the psychological distress [2, 3].
According UNHCR data of the 2015 the number of appli-cations for asylum increased in Europe more than doubling from 2013 [4, 5]; in this period 17 million of refugees and asylum seekers were outside their counties of origin [6].
From 2013 to 2015 Italy State responded positively to about 40% of asylum applications, a percentage that was lowered in 2016 [7].
The number of people in the world who suffer from politi-cal violence and war pursued by the war seems to grow by about 1% every year [8].
The nature of conflict changed in last 20 years consid-ering that the current war victims are civilians rather than combatants [3] causing a phenomenon of forced migration that represents, in many cases, the only option to survive. The forced migration, due to politics or war reasons pro-duces unmistakable psychological signs [5]. Migrants expe-rienced multiple stressful events before, during and after their travel: imprisonment, rape, ethnic cleansing, physical violence and torture. They often witnessed violence against or the death of loved ones [2]; persecutions, bereavement in their origin countries and discrimination in their host countries that contribute, successively, them to develop a “re-traumatization” post migration [5].
The exposure to interpersonal violence associated with emotional, sexual and physical abuse, torture and exploita-tion, and other atrocities committed in war, cause psycholog-ical distress that have strong impact on survivors life. Many psychological sequelae as destructive behaviors, substances misuse, self-harm, unsafe sexual practices and involvement in abusive relationship seems to be due to these traumatic conditions [9].
Moreover, forced migrants could experience deaths or suicides of their loved people, parents, kin, sons etc. These
Electronic supplementary material The online version of this article (https ://doi.org/10.1007/s1090 3-020-01055 -w) contains supplementary material, which is available to authorized users.
* Carlo Lai [email protected]
1 Department of Dynamic and Clinical Psychology, Sapienza University of Rome, Via degli Apuli, 1, 00185 Rome, Italy
2 A. Gemelli University Polyclinic, IRCSS Foundation, Rome, Italy
3 Sacred Heart Catholic University, Rome, Italy
1321Journal of Immigrant and Minority Health (2020) 22:1320–1346
1 3
bereavements could expose the survivor migrant to thoughts of death, to a probability of exacerbation of the psychopatho-logical symptoms that could last many years, and also to suicidal attempts. For this reason, it seems very important to explore what happens after the death or the suicide of a significant other, so to provide a proper and ad hoc care [10]. According to this clinical issue, it is important the knowl-edge of the neurobiological factors that underlie the suicide risk. Recent findings [11] showed an association between a biological dysregulation with the suicide attempts. This dys-regulation has been interpreted as a compensatory mecha-nism that involves the prolactin and the thyroid hormones, useful to corrects the reduced central serotonin activity. In the next future this neurobiological correlate could be use-ful to individuate a suicide risk in the clinical practice [11]. The displacement’s perception, the events that caused the migration and the hostility in the host country post migration (culture shock), seem to decrease life expectancy, and pro-duce insecurity, isolation and poorness, causing the devel-opment of mental illness including anxiety, depression and somatization [5].
In the last 20 years many types of psychological treat-ments—combined or not with pharmacological treatment—have been applied in migrants showing to be efficient [8–12].
Nowadays there are different systematic reviews that summarize the great number of studies on the efficacy of psychological intervention to post-migration symptoms. However, the four metanalysis published in the last ten years are focused on specific post-traumatic stress disorder PTSD outcome. The large number of studies published on this field allowed to perform metanalysis on specific therapeutic approaches and on specific psychological dimensions.
Aim of the present study was to assess, in adult migrants, the outcome of the main psychological interventions on post migration specific symptomatology: depression, anxiety and somatization.
Method
Search Strategy and Data Sources
The present systematic review and metanalysis has been registered on the International Prospective Register of Sys-tematic Reviews (PROSPERO).
The literature search was conducted on health data base that included: Pubmed, Scholar, Psych INFO, Published International Literature on Traumatic Stress (PILOT). Addi-tional studies were identified by cross-referencing.
Inclusion Criteria and Selection of Studies
The search strategy was based on the following main search components: “migrants”, “refugees”, “asylum seekers” (alone and combined). All randomized controlled trials (RCT), multiple perspective cohort trials (MCT) and sin-gle perspective cohort trials (SCT) written in English and assessing psychological and/or pharmacological interven-tion with pre and post evaluation of depression, anxiety, somatization were considered eligible for inclusion. Only experimental groups investigating psychological interven-tions were considered for comparisons. The control groups were eliminated as they included waiting lists or usual treat-ments. Included studies had to report at least one quantita-tive measure of depression and/or anxiety and/or somatiza-tion assessed before and after treatment.
Data Extraction and Coding
A qualitative systematic review for all 52 studies was per-formed (Table 1).
In the first metanalysis a comparison between pre-treat-ment and post-treatment values was been performed for each outcome (depression, anxiety, somatization) differ-entiating the trials based on research design (RCT, MCT, SCT). When two or more measurement scales for the same outcome (for example Hamilton Depression Rating Scale and Beck Depression Inventory) were administered in the same trial, the more frequent scale among all trials included in the meta-analysis was considered. Further sub-analysis, were made dividing the trials according 3 variables: sta-tus (refugees, asylum seekers), provenance (Middle East, Africa, Asia, Latin America), and treatment (narrative expo-sition therapies-NET, cognitive behavioural treatment-CBT, Dynamic therapies, combined psychological treatments, combined pharmacological/psychological treatments). The metanalysis was performed when at least 4 trials were homo-geneous for the considered variables.
Heterogeneity
Evaluation of heterogeneity was reported by the RevMan5.3 program. When the heterogeneity was high (despite the sig-nificance of the result), further sub-analysis (status, prov-enance, single treatment) were made.
Mean Differences
Pre and post intervention data of all the experimental treatments (within group) were inserted to calculate the means difference. For each trial mean difference, standard
1322 Journal of Immigrant and Minority Health (2020) 22:1320–1346
1 3
Tabl
e 1
Des
crip
tion
of th
e 27
/52
studi
es c
onsi
dere
d in
the
met
anal
ysis
Refe
renc
esRC
T C
ontro
lFo
llow
up
Sam
ples
Subj
ects
(tota
l and
fo
r exp
eri-
men
tal
sam
ples
pre
an
d po
st.
In o
rder
of
sam
ples
)
Stat
usPr
oven
ance
Out
com
eM
easu
res
Expe
rimen
tal s
ampl
esC
BT
treat
men
ts-
NET
-Psy
chod
inam
ic
ther
apy-
Com
bine
d Ps
ycho
logi
cal t
reat
-m
ent (
Com
bine
d ps
y)-C
ombi
ned
Phar
mac
holo
gica
l an
d ps
ycho
logi
cal
treat
men
t (C
ombi
ned
pha)
Find
ings
for
each
trea
tmen
t ap
plie
d ou
tcom
e
[13]
Aca
rturk
(2
015)
Yes
1 m
mC
BT
(EM
DR
)W
CL(
no
treat
men
t)29 15 14
Refu
gees
Siria
TEI
PTSD
Dep
ress
ion
IES-
RB
DI I
IC
BT
(EM
DR
)7
sess
ions
, 90
min
, w
eekl
y
PTSD
Dep
ress
ion:
sign
ifica
ntly
lo
wer
. rem
is-
sion
mai
n-ta
ined
[14]
Aca
rturk
(2
016)
Yes
1 m
mC
BT
(EM
DR
Foc
us re
cent
tra
uma
prol
onge
d at
pr
esen
t tim
e)W
CL
(no
treat
men
t)
98 49/3
749
/33
Refu
gees
Siria
TEI
PTSD
Dep
ress
ion
Neu
rops
y-ch
iatri
c sy
mpt
oma-
tolo
gy
HTQ
IES-
RB
DI-
IIH
SCL
25M
INI
CB
T (E
MD
R)
4 se
ssio
nsPT
SDD
epre
ssio
nIm
pact
eve
ntsi
gnifi
cant
ly
sym
ptom
s re
duce
d, a
fter
1 m
onth
mai
n-ta
ined
[15]
Ade
naue
r (2
011)
Yes
4 m
mN
ET (W
rited
by
ther
apist
s an
d re
adin
g hi
gh v
oice
to
subj
ect)
WLC
(no
treat
men
t or
antid
epre
ssan
ts)
34 16/1
118
/8
Refu
gees
Asy
lum
se
eker
s
PTSD
Dep
ress
ion
Dys
timya
Neu
roco
r-re
late
s
MEG
-ssV
EFC
SIC
WD
TECA
PSH
AM
-DM
INI
NET
12 se
ssio
ns, 1
08 m
in,
wee
kly
or b
iwee
kly
PTSD
Dep
ress
ion
sign
ifica
nt
effec
tiven
ess
sign
ifica
nt
Cha
ngin
g of
th
e ne
ural
co
rrel
ates
of
the
proc
essi
ng.
NET
incr
ease
d oc
cipi
tal a
nd
parie
tal a
ctiv
-ity
Afte
r 4 m
m.
mai
ntai
ned
1323Journal of Immigrant and Minority Health (2020) 22:1320–1346
1 3
Tabl
e 1
(con
tinue
d)
Refe
renc
esRC
T C
ontro
lFo
llow
up
Sam
ples
Subj
ects
(tota
l and
fo
r exp
eri-
men
tal
sam
ples
pre
an
d po
st.
In o
rder
of
sam
ples
)
Stat
usPr
oven
ance
Out
com
eM
easu
res
Expe
rimen
tal s
ampl
esC
BT
treat
men
ts-
NET
-Psy
chod
inam
ic
ther
apy-
Com
bine
d Ps
ycho
logi
cal t
reat
-m
ent (
Com
bine
d ps
y)-C
ombi
ned
Phar
mac
holo
gica
l an
d ps
ycho
logi
cal
treat
men
t (C
ombi
ned
pha)
Find
ings
for
each
trea
tmen
t ap
plie
d ou
tcom
e
[16]
Buh
man
n (2
016)
Yes
2 m
m4
mm
6 m
m8
mm
CB
T (c
omm
itmen
t the
rapy
an
d m
indf
ulne
ss a
nd
visu
al e
xpos
ition
)C
ombi
ned
Psy
(CB
T an
d ps
ycho
educ
atio
n an
d an
tidep
ress
ants
Com
bine
d Ph
a (p
sych
oe-
duca
tion
and
sertr
alin
e or
m
ians
erin
eW
LC (n
o tre
atm
ent)
280
70/5
271
/62
71/5
568
Refu
gees
Iraq
Iran
Leba
non
Yug
osla
via
Afg
hani
stan
PTSD
Anx
iety
Dep
ress
ion
Som
atiz
a-tio
nSt
ress
Pani
cIn
abili
tyPs
y-ch
ofisi
cal
HTQ
HSC
L25
SCL9
0H
AM
-DH
AM
-AVA
SSD
SW
HO
-5
CB
T16
sess
ions
, wee
kly
Com
bine
d ps
y4
sess
ions
, wee
kly
Com
bine
d ph
a 8
ses-
sion
s, w
eekl
y
Dep
ress
ion:
tre
atm
ent w
ith
antid
epre
ssan
t in
com
bina
-tio
n ps
ycho
e-du
catio
n w
as
asso
ciat
ed w
ith
sign
ifica
nt
decr
ease
and
si
gnifi
cant
ly
decr
ease
in
patie
nts r
ecei
v-in
g m
edic
ine
Anx
iety
: sig
nifi-
cant
effe
ct o
f m
edic
atio
n[1
7]C
arls
son
(201
8)Ye
sC
ombi
ned
Pha
(CB
T SM
fo
r acq
uire
cop
ing
skill
s, re
lax,
div
ided
atte
ntio
n,
beha
vior
al a
ctiv
atio
n)
and
phar
mac
olog
ical
(m
ians
erin
or s
ertra
line)
an
d ps
ycho
tera
pyC
ombi
ned
Pha
(CB
T C
R
psyc
hoed
ucat
ion,
cog
ni-
tive
rebu
ildin
g of
neg
ativ
e id
eas.)
and
pha
rmac
olog
i-ca
l (m
ians
erin
or s
ertra
-lin
e) a
nd p
sych
othe
rapy
TAU
140
62/5
364
/52
Refu
gees
Afg
hani
stan
Yug
osla
via
Iran
Iraq
Le
bano
n
PTSD
Pani
c,A
nxie
tyD
epre
ssio
nSo
mat
iza-
tion
Wel
lbei
ngD
isab
ility
,Fu
nctio
ning
;Sy
mpt
oma-
tolo
gy
HTQ
HSC
L 25
HA
M D
HA
M A
SCL
VAS
WH
OSD
SG
AF
SG
AF
F
Com
bine
d Ph
a(S
M a
nd C
R)
24 se
ssio
ns, a
nd
10 se
ssio
ns w
ith
med
ical
doc
tor,
16
sess
ions
with
psy
-ch
othe
rapi
st. 6
0 m
in
biw
eekl
y
PTSD
Som
atiz
atio
nFu
nctio
ning
Dis
abili
ty:
CR
sign
ifica
nt
effec
tD
epre
ssio
nA
nxie
tySo
mat
izat
ion:
SM si
gnifi
cant
eff
ects
Anx
iety
: bet
a si
gnifi
cant
1324 Journal of Immigrant and Minority Health (2020) 22:1320–1346
1 3
Tabl
e 1
(con
tinue
d)
Refe
renc
esRC
T C
ontro
lFo
llow
up
Sam
ples
Subj
ects
(tota
l and
fo
r exp
eri-
men
tal
sam
ples
pre
an
d po
st.
In o
rder
of
sam
ples
)
Stat
usPr
oven
ance
Out
com
eM
easu
res
Expe
rimen
tal s
ampl
esC
BT
treat
men
ts-
NET
-Psy
chod
inam
ic
ther
apy-
Com
bine
d Ps
ycho
logi
cal t
reat
-m
ent (
Com
bine
d ps
y)-C
ombi
ned
Phar
mac
holo
gica
l an
d ps
ycho
logi
cal
treat
men
t (C
ombi
ned
pha)
Find
ings
for
each
trea
tmen
t ap
plie
d ou
tcom
e
[18]
Hen
sel-
Ditt
man
n (2
011)
4 w
w6
mm
12 m
m
NET
(Req
uire
d by
ther
a-py
sts a
nd c
orre
cted
by
subj
ect w
ith re
adin
g)C
BT
(SIT
: cog
nitiv
e be
havi
our s
emist
ruct
ured
in
terv
entio
n)
28 14/1
013
/10
Asy
lum
se
eker
sPT
SDD
epre
ssio
nN
euro
sym
p-to
mat
olog
y
CAPS
HA
M-D
MIN
I
NET
10 se
ssio
ns, 9
0 m
inC
BT
(SIT
)10
sess
ions
PTSD
Syg
-ni
ficat
ivel
y re
duct
ion
with
N
ETM
aint
aine
d at
6
and
12 m
m[1
9]H
ijazi
Ala
a (2
014)
Yes
2 m
m4
mm
Brie
f NET
(Writ
e th
e th
erap
ists)
WLC
(no
treat
men
t)
63 41/3
922
Refu
gees
Iraq
PTSD
Dep
ress
ion
Post-
traum
atic
gr
owth
Psyc
holo
gi-
cal w
ellb
e-in
gSy
mpt
oma-
tolo
gy o
f str
ess p
ost-
traum
atic
Som
atiz
a-tio
n
HTQ
PTG
IW
HO
5B
DI-
IIPH
Q-1
5
Brie
f NET
3 se
ssio
ns,
60–9
0 m
in, w
eekl
y
PTSD
Dep
ress
ion
Som
atiz
atio
n:Re
duct
ion
at 2
an
d 4
mm
Wel
l bei
ng
impr
oved
at 2
an
d 4
mm
1325Journal of Immigrant and Minority Health (2020) 22:1320–1346
1 3
Tabl
e 1
(con
tinue
d)
Refe
renc
esRC
T C
ontro
lFo
llow
up
Sam
ples
Subj
ects
(tota
l and
fo
r exp
eri-
men
tal
sam
ples
pre
an
d po
st.
In o
rder
of
sam
ples
)
Stat
usPr
oven
ance
Out
com
eM
easu
res
Expe
rimen
tal s
ampl
esC
BT
treat
men
ts-
NET
-Psy
chod
inam
ic
ther
apy-
Com
bine
d Ps
ycho
logi
cal t
reat
-m
ent (
Com
bine
d ps
y)-C
ombi
ned
Phar
mac
holo
gica
l an
d ps
ycho
logi
cal
treat
men
t (C
ombi
ned
pha)
Find
ings
for
each
trea
tmen
t ap
plie
d ou
tcom
e
[20]
Hin
ton
(200
4)22
ww
Com
bine
d Ph
a (I
mm
edia
te
CB
T an
d SS
RI,
benz
odi-
azep
ine,
gab
apen
tin)
Com
bine
d Ph
a (D
elay
ed
CB
T an
d SS
RI,
benz
odi-
azep
ine,
gab
apen
tin)
24 12 12
Refu
gees
Vie
tnam
PTSD
Dep
ress
ion
Anx
iety
Pani
cPs
ycho
-ph
ysic
al
sym
ptom
a-to
logy
HTQ
ASI
HSC
L 25
NPA
SSO
PASS
Com
bine
d Ph
a im
med
iate
CB
T 11
se
ssio
nsC
ombi
ned
Pha
dela
yed
CB
T st
arte
d af
ter 1
1 se
ssio
ns fo
r an
othe
r 11
sess
ions
PTSD
Dep
ress
ion
Anx
iety
:Im
prov
emen
t si
nce
1 as
sess
-m
ent t
o 2
asse
ssm
ent f
or
imm
edia
te a
nd
RET
and
trea
t-m
ents
. Ass
ess-
men
t sin
ce 1
to
3 si
gnifi
cant
im
prov
emen
tPs
ycho
phys
ical
sy
mpt
omat
ol-
ogy,
impr
ove
sign
ifica
ntly
1326 Journal of Immigrant and Minority Health (2020) 22:1320–1346
1 3
Tabl
e 1
(con
tinue
d)
Refe
renc
esRC
T C
ontro
lFo
llow
up
Sam
ples
Subj
ects
(tota
l and
fo
r exp
eri-
men
tal
sam
ples
pre
an
d po
st.
In o
rder
of
sam
ples
)
Stat
usPr
oven
ance
Out
com
eM
easu
res
Expe
rimen
tal s
ampl
esC
BT
treat
men
ts-
NET
-Psy
chod
inam
ic
ther
apy-
Com
bine
d Ps
ycho
logi
cal t
reat
-m
ent (
Com
bine
d ps
y)-C
ombi
ned
Phar
mac
holo
gica
l an
d ps
ycho
logi
cal
treat
men
t (C
ombi
ned
pha)
Find
ings
for
each
trea
tmen
t ap
plie
d ou
tcom
e
[21]
Hin
ton
(200
5)28
ww
Com
bine
d Ph
a(im
med
iate
C
BT:
and
SSR
I, C
lona
z-ep
am, s
ocia
l sup
port)
Com
bine
d Ph
a (d
elay
ed
CB
T: a
nd S
SRI,
Con
az-
epam
, soc
ial s
uppo
rt)
40 20 20
Refu
gees
Cam
bogi
aPT
SDA
nxie
tySo
mat
iza-
tion
ASI
CAPS
N-P
ASS
O-P
ASS
N-F
SSO
-FSS
SCL9
0R
Com
bine
d Ph
a im
med
iate
CB
T 12
se
ssio
nsC
ombi
ned
Pha
dela
yed
CB
T af
ter
12 se
ssio
ns fo
r an
othe
r 12
sess
ions
PTSD
Anx
iety
Pani
cO
rthos
tatic
pa
ram
eter
sFl
ashb
acks
:Si
gnifi
cant
gr
oup
effec
t, tim
e eff
ect a
nd
inte
ract
ion
Follo
w u
p:Si
gnifi
cant
tim
e eff
ect a
nd
grou
p eff
ect
and
time
inte
r-ac
tion
On
all m
easu
res
Imm
edia
te
grou
p ha
s si
gnifi
cant
lo
wer
scor
es a
t se
cond
ass
ess-
men
t. D
elay
ed
CB
T im
prov
e-m
ent a
t 3
asse
ssm
ent
1327Journal of Immigrant and Minority Health (2020) 22:1320–1346
1 3
Tabl
e 1
(con
tinue
d)
Refe
renc
esRC
T C
ontro
lFo
llow
up
Sam
ples
Subj
ects
(tota
l and
fo
r exp
eri-
men
tal
sam
ples
pre
an
d po
st.
In o
rder
of
sam
ples
)
Stat
usPr
oven
ance
Out
com
eM
easu
res
Expe
rimen
tal s
ampl
esC
BT
treat
men
ts-
NET
-Psy
chod
inam
ic
ther
apy-
Com
bine
d Ps
ycho
logi
cal t
reat
-m
ent (
Com
bine
d ps
y)-C
ombi
ned
Phar
mac
holo
gica
l an
d ps
ycho
logi
cal
treat
men
t (C
ombi
ned
pha)
Find
ings
for
each
trea
tmen
t ap
plie
d ou
tcom
e
[22]
Neu
ner
(201
0)Ye
s6
mm
NET
(mor
e of
800
0 w
ords
w
ith su
perv
isio
n)C
BT
(Sta
biliz
atio
n or
ps
ycho
activ
e m
edic
atio
n an
d TF
T)
32 16 16
Turk
eyB
alka
nsA
fric
a
Dep
ress
ion
PTSD
Pain
PDS
CID
IH
SCL2
5CA
PSV
COV
NET
and
CB
T (S
tabi
-liz
atio
n an
d TF
T)9
sess
ions
, 120
min
, w
eekl
y an
d bi
wee
kly
PTSD
:Si
gnifi
cant
mai
n eff
ect t
ime
and
time
for
treat
men
t int
er-
actio
n. N
ET
sign
ifica
nt d
if-fe
renc
e w
ithin
an
d be
twee
n on
PTS
D, a
lso
to 6
mm
Pain
::Si
gnifi
cant
tim
e fo
r tre
atm
ent
inte
ract
ion
[23]
Paun
ovic
(2
001)
6 m
mC
ombi
ned
Pha
(CB
T:
Expo
sitio
n an
d tri
cycl
ics
and
SSR
Is) o
r ben
sodi
-az
epin
es o
r neu
role
ptic
s or
mus
cle
rela
xant
s or
neur
olep
tic)
Com
bine
d Ph
a (C
BT:
ex
posi
tion
and
cogn
i-tiv
e th
erap
y an
d co
ntro
l br
eath
ing
and
tricy
clic
s an
d SS
RIs
or b
enso
di-
azep
ines
or n
euro
lept
ics
or m
uscl
e re
laxa
nts o
r ne
urol
eptic
)
40 20 20
Refu
gees
PTSD
Dep
ress
ion
Anx
iety
Even
t im
pact
Qua
lity
life
CAPS
IVH
AM
DH
AM
APS
S-SR
IES
RB
DI
STA
I-S
QO
LIW
AS
BAI
AD
IS
Com
bine
d Ph
aC
BT
Expo
si-
tion,
8 se
ssio
ns,
20–6
0 m
in, w
eekl
yC
BT,
16–
20 se
ssio
ns,
60–1
20 m
in, w
eekl
y
PTSD
Dep
ress
ion
Anx
iety
Even
t im
pact
Qua
lity
life:
CB
T si
gnifi
cant
, be
tter a
t pos
t te
st. B
oth
effica
cy w
ithin
on
all
mea
sure
an
d m
aint
aine
d at
follo
w u
p
1328 Journal of Immigrant and Minority Health (2020) 22:1320–1346
1 3
Tabl
e 1
(con
tinue
d)
Refe
renc
esRC
T C
ontro
lFo
llow
up
Sam
ples
Subj
ects
(tota
l and
fo
r exp
eri-
men
tal
sam
ples
pre
an
d po
st.
In o
rder
of
sam
ples
)
Stat
usPr
oven
ance
Out
com
eM
easu
res
Expe
rimen
tal s
ampl
esC
BT
treat
men
ts-
NET
-Psy
chod
inam
ic
ther
apy-
Com
bine
d Ps
ycho
logi
cal t
reat
-m
ent (
Com
bine
d ps
y)-C
ombi
ned
Phar
mac
holo
gica
l an
d ps
ycho
logi
cal
treat
men
t (C
ombi
ned
pha)
Find
ings
for
each
trea
tmen
t ap
plie
d ou
tcom
e
[24]
Sonn
e (2
016)
Yes
Com
bine
d Ph
a (C
BT
and
man
ualiz
ed p
sych
othe
r-ap
y an
d so
cial
cou
nsel
ling
and
min
dful
lnes
s and
Se
rtral
ine
max
75
mg)
Com
bine
d Ph
a (C
BT
and
man
ualiz
ed p
sych
othe
r-ap
y an
d so
cial
cou
nsel
ling
and
min
dful
ness
and
Venl
afax
ine
max
50
mg)
Phar
mac
olog
ical
trea
tmen
t (s
ame
Sertr
alin
e)
207
108/
8898
/68
Refu
gees
Mid
dle
East
CPT
SDD
epre
ssio
nA
nxie
tySo
mat
iza-
tion
HTQ
HA
M D
HA
M A
HSC
L 25
SCL
90SD
SG
AF
GA
SVA
SC
SSW
HO
5
Com
bine
d Ph
a24
sess
ions
,10
sess
ions
med
ical
do
ctor
, 16
sess
ions
ps
ycho
logi
st
CPT
SDD
epre
ssio
nA
nxie
ty:
Goo
d re
sults
for
SSR
IFu
nctio
ning
:si
gnifi
cant
diff
er-
ence
with
in
for S
ertra
line
and
sign
ifica
nt
diffe
renc
es
betw
een
for
both
SAS
sign
ifica
nt
diffe
renc
es
both
with
inG
AF
S si
gnifi
-ca
nt d
iffer
ence
be
twee
n
1329Journal of Immigrant and Minority Health (2020) 22:1320–1346
1 3
Tabl
e 1
(con
tinue
d)
Refe
renc
esRC
T C
ontro
lFo
llow
up
Sam
ples
Subj
ects
(tota
l and
fo
r exp
eri-
men
tal
sam
ples
pre
an
d po
st.
In o
rder
of
sam
ples
)
Stat
usPr
oven
ance
Out
com
eM
easu
res
Expe
rimen
tal s
ampl
esC
BT
treat
men
ts-
NET
-Psy
chod
inam
ic
ther
apy-
Com
bine
d Ps
ycho
logi
cal t
reat
-m
ent (
Com
bine
d ps
y)-C
ombi
ned
Phar
mac
holo
gica
l an
d ps
ycho
logi
cal
treat
men
t (C
ombi
ned
pha)
Find
ings
for
each
trea
tmen
t ap
plie
d ou
tcom
e
[25]
Sten
mar
k (2
013)
Yes
1 m
m6
mm
NET
(no
writ
ten)
CB
T (F
ocal
izat
ion
and
help
for p
sych
olog
ical
pr
oble
m)
81 51/3
830
/22
Refu
gees
A
sylu
m
seek
ers
Mid
dle
East
PTSD
Dep
ress
ion
Neu
rolo
gica
l st
ate
CAPS
HA
M D
MIN
I
NET
: 10
sess
ions
, 90
min
CB
T (F
ocal
izat
ion)
: 10
sess
ions
86
min
PTSD
Dep
ress
ion:
Bot
h re
fuge
es
and
asy-
lum
seek
-er
s red
uced
th
eir m
enta
l pr
oble
ms.
Bot
h tre
atm
ent
sym
ptom
ato-
logi
chal
redu
c-tio
n bu
t mor
e pr
onou
nced
for
NET
. Bet
wee
n gr
oup
at 6
mm
no
sign
ifica
nt
effec
ts. C
APS
an
d H
AM
D
sign
ifica
nt
mai
n eff
ects
of
time
1330 Journal of Immigrant and Minority Health (2020) 22:1320–1346
1 3
Tabl
e 1
(con
tinue
d)
Refe
renc
esRC
T C
ontro
lFo
llow
up
Sam
ples
Subj
ects
(tota
l and
fo
r exp
eri-
men
tal
sam
ples
pre
an
d po
st.
In o
rder
of
sam
ples
)
Stat
usPr
oven
ance
Out
com
eM
easu
res
Expe
rimen
tal s
ampl
esC
BT
treat
men
ts-
NET
-Psy
chod
inam
ic
ther
apy-
Com
bine
d Ps
ycho
logi
cal t
reat
-m
ent (
Com
bine
d ps
y)-C
ombi
ned
Phar
mac
holo
gica
l an
d ps
ycho
logi
cal
treat
men
t (C
ombi
ned
pha)
Find
ings
for
each
trea
tmen
t ap
plie
d ou
tcom
e
[26]
Ter H
eide
(2
011)
Yes
3 m
mC
BT
(Sta
biliz
atio
n: h
ere
and
now
on
traum
a m
emor
y)C
BT
(EM
DR
)
20 10/5
10/5
Refu
gees
A
sylu
m
Seek
ers
Afg
hani
stan
Alg
eria
Bos
nia
Turc
hia
Ang
ola
Leba
non
PTSD
Dep
ress
ion
Anx
iety
Qua
lity
life
Neu
rops
y-ch
iatri
c st
ate
HTQ
HSC
L 25
WH
OQ
OL
brie
fSC
DI 1
MIN
I 10
CB
T (S
tabi
lizat
ion
and
EMD
R)
11 se
ssio
ns, w
eekl
y an
d bi
wee
kly
PTSD
: sig
nifi-
cant
diff
eren
ce
betw
een
cond
ition
s, EM
DR
som
e im
prov
emen
t. Si
gnifi
cant
di
ffere
nces
be
twee
n tre
atm
ents
fo
r HSC
L-25
(a
nxie
ty a
nd
depr
essi
on)
and
WH
O-
QO
L, E
MD
R
impr
ovem
ents
[27]
Wan
g (2
017)
Yes
3 m
m6
mm
Com
bine
d Ps
y im
med
iate
(C
BT
psyc
hoth
erap
y,
grou
p th
erap
y an
d m
ulti-
vita
min
ic)
Com
bine
d Ps
y de
laye
d:
cont
rol (
CB
T ps
ycho
ter-
apy,
gro
upth
erap
y de
laye
d af
ter 3
mm
and
mul
tivita
-m
inic
imm
edia
te)
34 13 15
Asi
lum
se
eker
sK
osov
oPT
SDD
epre
ssio
nA
nxie
tyPa
nic
HTQ
HSC
L 25
SF.M
PQW
B F
AC
ES
PRS
WH
OD
AS
Com
bine
d Ps
yC
BT
10 se
ssio
ns,
90 m
in, g
roup
th
erap
y 10
sess
ion,
90
min
wee
kly
PTSD
: Sig
nifi-
cant
the
effec
t of
inte
rven
tion
at 6
mm
Pain
: at 3
mm
Mul
tiple
pe
rspe
c-tiv
e co
hort
trial
s
1331Journal of Immigrant and Minority Health (2020) 22:1320–1346
1 3
Tabl
e 1
(con
tinue
d)
Refe
renc
esRC
T C
ontro
lFo
llow
up
Sam
ples
Subj
ects
(tota
l and
fo
r exp
eri-
men
tal
sam
ples
pre
an
d po
st.
In o
rder
of
sam
ples
)
Stat
usPr
oven
ance
Out
com
eM
easu
res
Expe
rimen
tal s
ampl
esC
BT
treat
men
ts-
NET
-Psy
chod
inam
ic
ther
apy-
Com
bine
d Ps
ycho
logi
cal t
reat
-m
ent (
Com
bine
d ps
y)-C
ombi
ned
Phar
mac
holo
gica
l an
d ps
ycho
logi
cal
treat
men
t (C
ombi
ned
pha)
Find
ings
for
each
trea
tmen
t ap
plie
d ou
tcom
e
[28]
Dro
zdek
(2
010)
Yes
6 m
m12
mm
Com
bine
d Ps
y 3*
3C
ombi
ned
Psy
3*2
Com
bine
d Ps
y 2*
2D
ynam
ic: 1
*1C
ontro
l (Ph
arm
acho
logi
cal)
5 ph
ases
:1
norm
s, va
lues
of g
roup
tre
atm
ent,
psyc
hoed
uca-
tion,
alli
ance
, ass
essm
ent
of p
robl
ems,
treat
men
t go
als a
nd sy
mpt
oms
2 pr
esen
tatio
ns, d
amag
e co
re b
elie
fs, f
ear o
f los
s co
ntro
l, gu
ilt, s
ham
e,
grie
f, ac
know
ledg
emen
t, re
silie
nce
3 te
lling
the
traum
a sto
ry,
expo
sure
and
cog
nitiv
e re
struc
turin
g4
reco
nnec
ting
the
pres
ent
with
pas
t and
futu
re, d
am-
age
core
bel
iefs
, rol
es a
nd
iden
tity,
cop
ing
strat
egie
s, cu
rren
t wor
ries a
nd fu
ture
ou
tlook
, res
ilien
ce5
psyc
hoed
ucat
ion,
rela
pse
prev
entio
n, tr
eatm
ent
eval
uatio
n, fa
rew
ell r
itual
. (e
mpl
oyed
din
amic
and
be
havi
or te
cniq
ues)
88 34 19 11 6 18
Refu
gees
A
sylu
m
seek
ers
Iraq
Iran
Afg
hani
stan
PTSD
Dep
ress
ion
Anx
iety
Stre
ssPs
ycho
fisic
sy
mpt
oms
Psyc
hotic
sy
mpt
oms
HTQ
HSC
L-20
SLC
-90
Psy-
chot
icis
m
scal
e
Spec
ifica
lly:
Gro
up th
erap
y 58
ses-
sion
s, 90
min
, dai
lyN
o ve
rbal
ther
apy
58 se
ssio
ns, 7
5 m
in,
daily
Com
bine
d Ps
y 3*
3N
o ve
rbal
psy
cho-
ther
apy,
3 se
ssio
ns
(psy
chom
otor
bo
dy th
erap
y, a
rt th
erap
y, m
usic
th
erap
y) G
roup
th
erap
y, 2
sess
ions
, 3
days
wee
kC
ombi
ned
Psy
3*2
sam
e th
ing
of 3
*3
but 2
day
s wee
k)C
ombi
ned
Psy
2*2
psyc
hoth
erap
y 2
sess
ions
Gro
up th
erap
y 1
ses-
sion
s, 2
days
wee
kD
ynam
ic 1
*1Su
ppor
t, 48
sess
ions
, w
eekl
y
PTSD
Dep
ress
ion
Anx
iety
Psyc
hotic
ism
Com
bine
d 3*
3 an
d 3*
2 Si
g-ni
fican
t effe
ct
with
inPT
SD (
2*2)
Diff
eren
ces
betw
een
not
stat
istic
ally
si
gnifi
cant
1332 Journal of Immigrant and Minority Health (2020) 22:1320–1346
1 3
Tabl
e 1
(con
tinue
d)
Refe
renc
esRC
T C
ontro
lFo
llow
up
Sam
ples
Subj
ects
(tota
l and
fo
r exp
eri-
men
tal
sam
ples
pre
an
d po
st.
In o
rder
of
sam
ples
)
Stat
usPr
oven
ance
Out
com
eM
easu
res
Expe
rimen
tal s
ampl
esC
BT
treat
men
ts-
NET
-Psy
chod
inam
ic
ther
apy-
Com
bine
d Ps
ycho
logi
cal t
reat
-m
ent (
Com
bine
d ps
y)-C
ombi
ned
Phar
mac
holo
gica
l an
d ps
ycho
logi
cal
treat
men
t (C
ombi
ned
pha)
Find
ings
for
each
trea
tmen
t ap
plie
d ou
tcom
e
[29]
Dro
zdek
(2
012)
Yes
12 m
mC
ombi
ned
Psy
3*3
Com
bine
d Ps
y 3*
2C
ombi
ned
Psy
2*2
WC
L (fo
r 6 m
m n
o tre
at-
men
t)5
phas
es:
1 no
rms,
valu
es o
f gro
up
treat
men
t, ps
ycho
educ
a-tio
n, a
llian
ce, a
sses
smen
t of
pro
blem
s, tre
atm
ent
goal
s and
sym
ptom
s2
pres
enta
tions
, dam
age
core
bel
iefs
, fea
r of l
oss
cont
rol,
guilt
, sha
me,
gr
ief,
ackn
owle
dgem
ent,
resi
lienc
e3
telli
ng th
e tra
uma
story
, ex
posu
re a
nd c
ogni
tive
restr
uctu
ring
4 re
conn
ectin
g th
e pr
esen
t w
ith p
ast a
nd fu
ture
, dam
-ag
e co
re b
elie
fs, r
oles
and
id
entit
y, c
opin
g str
ateg
ies,
curr
ent w
orrie
s and
futu
re
outlo
ok, r
esili
ence
5 ps
ycho
educ
atio
n, re
laps
e pr
even
tion,
trea
tmen
t ev
alua
tion,
fare
wel
l ritu
al.
(em
ploy
ed d
ynam
ic a
nd
beha
vior
tech
niqu
es)
71 27 22 7 16
Refu
gees
A
sylu
m
seek
ers
Iran
, Afg
h-an
izta
nPT
SDD
epre
ssio
nA
nxie
tySt
ress
Psyc
ho-
phys
ic
sym
ptom
s
HTQ
HSC
L20
SLC
90
Spec
ifica
lly:
Gro
up th
erap
y 58
ses-
sion
s, 90
min
, dai
lyN
o ve
rbal
ther
apy
58 se
ssio
ns, 7
5 m
in,
daily
Com
bine
d Ps
y 3*
3N
o ve
rbal
psy
cho-
ther
apy,
3 se
ssio
ns
(psy
chom
otor
bo
dy th
erap
y, a
rt th
erap
y, m
usic
th
erap
y) G
roup
th
erap
y, 2
sess
ions
, 3
days
wee
kC
ombi
ned
Psy
3*2
sam
e th
ing
of 3
*3
but 2
day
s wee
k)C
ombi
ned
Psy
2*2
psyc
hoth
erap
y 2
sess
ions
Gro
up th
erap
y 1
ses-
sion
s, 2
days
wee
k
PTSD
Dep
ress
ion
Anx
iety
Stre
ssPs
ycho
phys
ics
sym
ptom
sTh
e tre
atm
ents
w
ere
sign
ifi-
cant
but
2*2
no
t sig
nific
ant
effec
t on
PTSD
No
sign
ifica
nt
diffe
renc
e be
twee
n tre
at-
men
ts a
nd
treat
men
ts a
nd
cont
rol,
but
3*3
and
3*2
mor
e effi
cacy
of
2*2
1333Journal of Immigrant and Minority Health (2020) 22:1320–1346
1 3
Tabl
e 1
(con
tinue
d)
Refe
renc
esRC
T C
ontro
lFo
llow
up
Sam
ples
Subj
ects
(tota
l and
fo
r exp
eri-
men
tal
sam
ples
pre
an
d po
st.
In o
rder
of
sam
ples
)
Stat
usPr
oven
ance
Out
com
eM
easu
res
Expe
rimen
tal s
ampl
esC
BT
treat
men
ts-
NET
-Psy
chod
inam
ic
ther
apy-
Com
bine
d Ps
ycho
logi
cal t
reat
-m
ent (
Com
bine
d ps
y)-C
ombi
ned
Phar
mac
holo
gica
l an
d ps
ycho
logi
cal
treat
men
t (C
ombi
ned
pha)
Find
ings
for
each
trea
tmen
t ap
plie
d ou
tcom
e
[30]
Laks
hmi
Vija
ya-
kum
ar
(201
7)
Yes
6 m
m15
mm
Dyn
amic
(CA
SP: e
mot
iona
l su
ppor
t con
tact
with
a
volu
ntar
y co
mm
unity
and
su
ppor
t of t
he p
lann
ing
card
s at m
omen
t of d
is-
tress
. Med
ical
doc
tor)
Con
trol
(to p
rovi
de th
e te
leph
one
num
ber t
hat c
an u
se fo
r su
ppor
tive
help
)
485
288/
139
187
Refu
gees
Tam
il N
adu
(Ind
ia)
Dep
ress
ion
Suic
ide
idea
-tio
nPT
SDA
lcoh
ol
abus
e
Bec
k SS
I (in
W
HO
)SU
PRE
MIS
SC
ESD
-RA
UD
ITPC
L
Dyn
amic
(CA
SP)
60 se
ssio
ns, 4
mm
m
edic
al d
octo
r
PTSD
and
D
epre
ssio
n,
sign
ifica
nt
diffe
renc
es
betw
een
on,
and
redu
ce o
f 2
unite
s the
m
eans
of t
he
scor
es (s
igni
fi-ca
nt w
ithin
)[3
1]W
eins
tein
(2
016)
Yes
Dyn
amic
(Nee
d sa
tisfa
ctio
n B
asic
psy
chol
ogic
al n
eed
Relie
ves t
he fr
ustra
tions
lin
ked
to th
e au
tono
my
com
pete
nces
and
rela
tion-
ship
s nee
ds)
Con
trol:
no tr
eatm
ent
41 24 17
Refu
gees
Siria
Nee
d fr
us-
tratio
nPT
SDdi
tress
Dep
ress
ion
Psyc
holo
gica
l ne
ed sc
ale
PSS
CES
-DST
AI
17 it
ems s
elf
repo
rted
Dyn
amic
(Nee
d sa
tis-
fact
ion)
7 se
ssio
ns, 2
4 m
in,
daily
Dep
ress
ion
and
stres
s de
crea
sed
with
on
e w
eek
long
in
terv
entio
n bu
t not
sig-
nific
antly
and
al
levi
ated
nee
d fr
ustra
tion
Sing
le p
er-
spec
tive
coho
rt tri
als
[32]
Bru
ne
(201
4)C
ombi
ned
Pha
refu
gees
(p
sych
odyn
amic
and
C
BT
and
antid
epre
ssan
t, an
xiol
ytic
, hyp
notic
))C
ombi
ned
Pha
no le
gal s
ta-
tus (
psyc
hody
nam
ic a
nd
CB
T an
d an
tidep
ress
ant,
anxi
olyt
ic, h
ypno
tic))
190
121
69
Refu
gees
A
sylu
m
seek
ers
Yug
osla
via
Am
eric
a La
tina
Turc
hia
Afr
ica
Iraq
Russ
ia
Dep
ress
ion
Psyc
hoso
cial
di
stres
s
HA
M-D
CG
IC
ombi
ned
Pha
daily
,ph
arm
acol
ogi-
cal t
reat
men
t, 22
mon
ths
Dep
ress
ion:
sig-
nific
ant r
esul
ts
at e
nd th
erap
y fo
r ref
ugee
s. Ps
ycho
soci
al
distr
ess:
no
sign
ifica
nt d
if-fe
renc
es w
ithin
an
d be
twee
n
1334 Journal of Immigrant and Minority Health (2020) 22:1320–1346
1 3
Tabl
e 1
(con
tinue
d)
Refe
renc
esRC
T C
ontro
lFo
llow
up
Sam
ples
Subj
ects
(tota
l and
fo
r exp
eri-
men
tal
sam
ples
pre
an
d po
st.
In o
rder
of
sam
ples
)
Stat
usPr
oven
ance
Out
com
eM
easu
res
Expe
rimen
tal s
ampl
esC
BT
treat
men
ts-
NET
-Psy
chod
inam
ic
ther
apy-
Com
bine
d Ps
ycho
logi
cal t
reat
-m
ent (
Com
bine
d ps
y)-C
ombi
ned
Phar
mac
holo
gica
l an
d ps
ycho
logi
cal
treat
men
t (C
ombi
ned
pha)
Find
ings
for
each
trea
tmen
t ap
plie
d ou
tcom
e
[33]
Car
lsso
n (2
010)
9 m
m23
mm
Com
bine
d Ps
y (p
sych
o-dy
nam
ic, s
ocia
l cou
n-se
lling
, phy
siot
hera
py,
med
ical
ass
istan
ce, s
ome
sero
toni
n)
69/6
2Re
fuge
esIr
aqD
epre
ssio
nA
nxie
tyD
istre
ssPT
SDQ
ualit
y lif
eEv
ent
impa
ct
HTQ
,H
AM
-DH
SCL2
5 W
HO
QO
Lbr
ief
Qua
lity
life:
si
gnifi
cant
di
ffere
nces
at
9 m
mA
nxie
ty: s
ig-
nific
ant d
iffer
-en
ces b
etw
een
9 an
d 23
mm
Sign
ifica
nt
diffe
renc
es a
t 23
mm
for a
ll m
easu
res i
n 1/
3 pa
tient
s[3
4]D
’Ard
enne
(2
007)
CB
T re
fuge
es in
terp
rete
r tra
uma
foca
lizat
ion,
ex
posi
tion)
CB
T re
fuge
es n
o in
terp
rete
r (tr
aum
a fo
caliz
atio
n,
expo
sitio
n)C
BT
asyl
um se
eker
s (tr
aum
a fo
caliz
atio
n,
expo
sitio
n)
112
36 31 45
Asy
lum
se
eker
sRe
fuge
es
PTSD
Even
t im
pact
Dep
ress
ion
Qua
lity
life
IES
BD
I Man
-ch
este
r sh
ort
asse
ssm
ent
qual
ity li
fe
CB
T (fo
caliz
atio
n,
expo
sitio
n)9.
1 se
ssio
ns, 6
0 m
in,
wee
kly
Dep
ress
ion:
si
gnifi
cant
di
ffere
nces
fo
r all
grou
ps,
mor
e in
asy
lum
se
eker
sEv
ent i
mpa
ct:
sign
ifica
nt d
if-fe
renc
es fo
r all
grou
ps, m
ore
for a
sylu
m
seek
ers
Qua
lity
life:
si
gnifi
cant
di
ffere
nces
for
refu
gees
no
inte
rpre
ter a
nd
asyl
um se
eker
s
1335Journal of Immigrant and Minority Health (2020) 22:1320–1346
1 3
Tabl
e 1
(con
tinue
d)
Refe
renc
esRC
T C
ontro
lFo
llow
up
Sam
ples
Subj
ects
(tota
l and
fo
r exp
eri-
men
tal
sam
ples
pre
an
d po
st.
In o
rder
of
sam
ples
)
Stat
usPr
oven
ance
Out
com
eM
easu
res
Expe
rimen
tal s
ampl
esC
BT
treat
men
ts-
NET
-Psy
chod
inam
ic
ther
apy-
Com
bine
d Ps
ycho
logi
cal t
reat
-m
ent (
Com
bine
d ps
y)-C
ombi
ned
Phar
mac
holo
gica
l an
d ps
ycho
logi
cal
treat
men
t (C
ombi
ned
pha)
Find
ings
for
each
trea
tmen
t ap
plie
d ou
tcom
e
[35]
Dro
zdek
(2
014)
12 m
m24
mm
Com
bine
d Ps
y 3*
3C
ombi
ned
Psy
3*2
Com
bine
d Ps
y 2*
22
nonv
erba
l5
phas
es:
1 no
rms,
valu
es o
f gro
up
treat
men
t, ps
ycho
educ
a-tio
n, a
llian
ce, a
sses
smen
t of
pro
blem
s, tre
atm
ent
goal
s and
sym
ptom
s2
pres
enta
tions
, dam
age
core
bel
iefs
, fea
r of l
oss
cont
rol,
guilt
, sha
me,
gr
ief,
ackn
owle
dgem
ent,
resi
lienc
e3
telli
ng th
e tra
uma
story
, ex
posu
re a
nd c
ogni
tive
restr
uctu
ring
4 re
conn
ectin
g th
e pr
esen
t w
ith p
ast a
nd fu
ture
, dam
-ag
e co
re b
elie
fs, r
oles
and
id
entit
y, c
opin
g str
ateg
ies,
curr
ent w
orrie
s and
futu
re
outlo
ok, r
esili
ence
5 ps
ycho
educ
atio
n, re
laps
e pr
even
tion,
trea
tmen
t ev
alua
tion,
fare
wel
l ritu
al.
(em
ploy
ed d
ynam
ic a
nd
beha
vior
tech
niqu
es)
69/6
6(a
ll)Re
fuge
es
Asy
lum
seek
ers
Iran
Afg
han-
istan
PTSD
Dep
ress
ion
Anx
iety
HTQ
HSC
L20
Com
bine
d Ps
y 85
se
ssio
ns:
1 ph
ase
10 se
ssio
ns2
phas
e 20
sess
ions
3 ph
ase
10 se
ssio
ns4
phas
e 30
sess
ions
5 ph
ase
15 se
ssio
nsSp
ecifi
cally
:G
roup
ther
apy
85 se
s-si
ons,
90 m
in, d
aily
No
verb
al th
erap
y85
sess
ions
, 75
min
, da
ilyC
ombi
ned
Psy
3*3
No
verb
al p
sych
o-th
erap
y, 3
sess
ions
(p
sych
omot
or
body
ther
apy,
art
ther
apy,
mus
ic
ther
apy)
Gro
up
ther
apy,
2 se
ssio
ns,
3 da
ys w
eek
Com
bine
d Ps
y 3*
2 sa
me
thin
g of
3*3
bu
t 2 d
ays w
eek)
Com
bine
d Ps
y 2*
2 ps
ycho
ther
apy
2 se
ssio
nsG
roup
ther
apy
1 se
s-si
ons,
2 da
ys w
eek
Dyn
amic
1*1
Supp
ort,
1 se
ssio
ns,
wee
kly
PTSD
, Anx
iety
, D
epre
ssio
n si
gnifi
cant
re
duct
ion
for
3*3
treat
men
tA
nxie
ty
sign
ifica
nt
diffe
renc
es in
re
fuge
es
1336 Journal of Immigrant and Minority Health (2020) 22:1320–1346
1 3
Tabl
e 1
(con
tinue
d)
Refe
renc
esRC
T C
ontro
lFo
llow
up
Sam
ples
Subj
ects
(tota
l and
fo
r exp
eri-
men
tal
sam
ples
pre
an
d po
st.
In o
rder
of
sam
ples
)
Stat
usPr
oven
ance
Out
com
eM
easu
res
Expe
rimen
tal s
ampl
esC
BT
treat
men
ts-
NET
-Psy
chod
inam
ic
ther
apy-
Com
bine
d Ps
ycho
logi
cal t
reat
-m
ent (
Com
bine
d ps
y)-C
ombi
ned
Phar
mac
holo
gica
l an
d ps
ycho
logi
cal
treat
men
t (C
ombi
ned
pha)
Find
ings
for
each
trea
tmen
t ap
plie
d ou
tcom
e
[36]
Hal
vors
en
(201
0)1
mm
6 m
mN
ET (n
o ve
rbal
exp
ositi
on
all t
raum
atic
eve
nt, t
he
biog
raph
y is
reco
rded
and
co
rrec
ted)
16Re
fuge
es
Asy
lum
se
eker
s
Afg
hani
stan
Eritr
eaK
osov
oEt
iopi
aIr
anSu
dan
Togo
Iraq
PTSD
Dep
ress
ion
CAPS
HA
M-D
Soci
odem
o-gr
aphi
c qu
estio
n-na
ire
NET
3ses
sion
sPT
SD: s
igni
fi-ca
nt d
iffer
ence
pr
e-po
st tre
atm
ent,
pret
reat
men
t-fo
llow
up
and
post
treat
men
t-fo
llow
up
Dep
ress
ion:
sig-
nific
ant d
iffer
-en
ce b
etw
een
pret
reat
men
t- fo
llow
up
Avo
idan
ce:
sign
ifica
nt
diffe
renc
e pr
e-po
st tre
atm
ent,
pret
reat
men
t-fo
llow
up
Hyp
erar
ousa
l: si
gnifi
cant
di
ffere
nce
betw
een
pret
reat
men
t-fo
llow
up
[37]
Rag
hava
n (2
013)
6 m
m18
mm
Com
bine
d Ph
a (m
edic
ine
prog
ram
of s
urvi
vors
of
tortu
re: i
ndiv
idua
l and
gr
oup
ther
apy,
cou
nsel
-lin
g, fr
ee m
edic
ine)
178/
172
Refu
gees
A
sylu
m
seek
ers
Euro
paA
mer
ica
Afr
ica
Gen
eral
sy
mpt
oms
PTSD
Dep
ress
ion
Anx
iety
Som
atiz
a-tio
n
HTQ
BSI
Com
bine
d Ph
a7.
5 se
ssio
ns, d
aily
Dep
ress
ion
Anx
iety
Som
atiz
atio
nPT
SDsi
gnifi
cant
diff
er-
ence
s at 6
mm
1337Journal of Immigrant and Minority Health (2020) 22:1320–1346
1 3
Tabl
e 1
(con
tinue
d)
Refe
renc
esRC
T C
ontro
lFo
llow
up
Sam
ples
Subj
ects
(tota
l and
fo
r exp
eri-
men
tal
sam
ples
pre
an
d po
st.
In o
rder
of
sam
ples
)
Stat
usPr
oven
ance
Out
com
eM
easu
res
Expe
rimen
tal s
ampl
esC
BT
treat
men
ts-
NET
-Psy
chod
inam
ic
ther
apy-
Com
bine
d Ps
ycho
logi
cal t
reat
-m
ent (
Com
bine
d ps
y)-C
ombi
ned
Phar
mac
holo
gica
l an
d ps
ycho
logi
cal
treat
men
t (C
ombi
ned
pha)
Find
ings
for
each
trea
tmen
t ap
plie
d ou
tcom
e
[38]
Sier
ra V
an
Wyk
(201
2)
6,9
mm
Com
bine
d Ps
y (p
sych
oe-
duca
tion,
stru
ctur
ed sk
ills
base
d th
erap
y, e
xpre
s-si
ve th
erap
y, su
ppor
tive
ther
apy,
cou
ples
and
fa
mily
ther
apy,
CB
T,
expo
sitio
n)
70/6
2Re
fuge
esB
urm
aPT
SDD
epre
ssio
nA
nxie
tySo
mat
iza-
tion
HTQ
HSC
L 37
Post
Mig
ra-
tion
Livi
ngD
ifficu
lties
C
heck
list
Com
bine
d Ps
y2–
3 se
ssio
ns,
120–
150
min
PTSD
Dep
ress
ion
Anx
iety
Som
atiz
atio
n:Si
gnifi
cant
de
crea
se sy
mp-
tom
s[3
9]W
hits
ett
(201
7)12
mm
Com
bine
d Ps
y(g
roup
and
indi
vidu
al
ther
apy:
CB
T, p
sych
-oe
duca
tion,
com
bing
su
ppor
tive,
inte
rper
sona
l an
d ex
posu
re te
chni
ques
, sl
eep
hygi
ene,
rela
xatio
n,
cogn
itive
restr
uctu
ring,
so
cial
supp
ort)
105
Asy
lum
se
eker
sA
zerb
aija
n B
urki
na
Faso
B
urun
di
Cam
eroo
n C
entra
l A
fric
an
Repu
blic
of
Con
go
Eritr
ea
Ethi
opia
Li
beria
M
ali N
epal
Pa
kist
an
Russ
ia
Rw
anda
Si
erra
Le
one
Togo
U
gand
a
PTSD
Anx
iety
Dep
ress
ion
Tortu
re
HU
RID
OC
SH
TQH
SCL
25
Com
bine
d Ps
y ps
ycho
ther
apy
and
grou
p th
erap
y,
Supp
ortiv
e, p
sych
-oe
duca
tion,
CB
T an
d ex
posi
tion
and
repr
oces
sing
tra
uma,
wee
kly
PTSD
Dep
ress
ion
Anx
iety
:Si
gnifi
cant
re
duct
ion
1338 Journal of Immigrant and Minority Health (2020) 22:1320–1346
1 3
deviation, number of subjects at pre and post intervention for one of the three outcomes were provided.
Metanalytic Techniques Calculation
Mean differences (random effects model) were computed using Review Manager version 5.3. (RevMan5.3). All the mean differences were computed for depression, anxiety and somatization outcome. The program provides the following results: Heterogeneity (Tau2, Chi2, I2) and test for overall effect (Z). Publication bias significance was evaluated by inspecting the funnel plots as implemented in RevMan5.3.
Results
Study Selection
440 research papers about migrants, refugees or asylum seeker, were included as reported in Fig. 1 (PRISMA). Afterwards the research papers on migrants receiving psy-chological or/and pharmacological treatment were selected, resulting 108 studies. A more specific full view paper investigation on this subsample of studies, identified only the research paper on migrants with a psychological and/or pharmacological treatment with pre and post evaluation of depression and/or anxiety and/or somatization, resulting 52 studies (1997–2018). These fifty-two studies were included in the systematic review (Supplementary material). Of these 52 studies, 25 were excluded from the metanalysis due to lacking data. Finally, 27 studies (2004–2018) were included for the metanalysis (Review Manager 5.3 program was set for calculating mean differences, standard deviation and number of subjects through a random effects model.
Excluded Studies
332 on 440 studies were excluded due to the lack of clinical intervention. Of the resulting 108 studies, 56 studies were excluded due to the following reasons: 2 studies were wrote in German language; 1 study was performed on a sample of military personnel; 1 study was conducted on a sample of interpreters; 5 studies were performed on patients who were treated in own country; 11 studies were conducted on patients with multiple trauma; 10 studies were reviews; 14 studies did not present a pre-intervention evaluation; 1 study was conducted on a single case; 11 studies were conducted on an underage sample. Of the resulting 52 studies, 25 stud-ies did not report useful data and the authors did not answer to an email request of data or their email address was not available.
Tabl
e 1
(con
tinue
d)
ASI a
ddic
tion
seve
rity
inde
x, A
UD
IT A
lcoh
ol u
se d
isor
der i
dent
ifica
tion
test,
BD
I Bec
k de
pres
sion
inve
ntor
y, B
eck
SSI s
cale
for s
uici
dal i
deat
ion,
BSI
brie
f sym
ptom
inve
ntor
y, C
AFES
Coff
ee
and
fam
ily e
duca
tion
and
supp
ort,
CBT
cog
nitiv
e be
havi
or tr
eatm
ent,
CES
-D C
ente
r for
Epi
dem
iolo
gic
Stud
ies
Dep
ress
ion
Scal
e, C
ESD
-R C
ente
r for
Epi
dem
iolo
gic
Stud
ies
Dep
ress
ion
Scal
e re
vise
d, C
GI c
linic
al g
loba
l im
pres
sion
, CID
I com
posi
te in
tern
atio
nal d
iagn
ostic
inte
rvie
w, C
ombi
ned
Pha
com
bine
d ps
ycho
logi
cal w
ith p
harm
acol
ogic
al tr
eatm
ents
, Com
bine
d Ps
y co
mbi
ned
psyc
holo
gica
l tre
atm
ents
, CPT
cog
nitiv
e pr
oces
sing
ther
apy,
CR
cogn
itive
restr
uctu
ring,
CRO
P gr
oup
faci
litat
or fo
r cul
ture
sen
sitiv
e an
d re
sour
ces
orie
nted
pee
r, C
SI c
linic
ian
struc
ture
d in
ter-
view
, CSS
cris
is su
ppor
t sca
le, C
VDTE
che
cklis
t of w
ar d
eten
tion
and
tortu
re e
vent
s, D
T dy
nam
ic th
erap
y, E
MD
R ey
e m
ovem
ent d
esen
sitiz
atio
n an
d re
proc
essi
ng, E
MD
R-R-
TEP
eye
mov
emen
t de
sens
itiza
tion
and
repr
oces
sing
rece
nt tr
aum
atic
epi
sode
pro
toco
l, EU
ROH
IS-Q
OL
GAF
glo
bal a
sses
smen
t of f
unct
ioni
ng, h
hou
rs, H
AM-A
Ham
ilton
Anx
iety
ratin
g sc
ale,
HAM
-D H
amilt
on
depr
essi
on ra
ting
scal
e, H
RSD
Ham
ilton
ratin
g sc
ale
depr
essi
on, H
SCL
(20,
25) H
opki
ns S
ympt
om C
heck
list,
HTQ
Har
vard
Tra
uma
Que
stion
naire
, HU
RID
OC
S ev
ents
sta
ndar
d fo
rmat
s: a
tool
fo
r doc
umen
ting
hum
an ri
ghts
vio
latio
ns, I
ES im
pact
of e
vent
sca
le, I
ES-R
impa
ct o
f eve
nts
scal
e re
vise
d, IP
T in
terp
erso
nal p
sych
othe
rapy
, ISE
L In
terp
erso
nal S
uppo
rt Ev
alua
tion
List,
MEG
-ss
VEF
mag
neto
ence
phal
ogra
phy
stead
y-st
ate
visu
al e
voke
d fie
lds,
MG
mon
itorin
g gr
oup,
MIN
I m
ini i
nter
natio
nal n
euro
psyc
hiat
ric in
terv
iew
, NET
nar
rativ
es e
xper
ienc
es tr
eatm
ent,
N-F
SS
neur
al fl
ashb
acks
sev
erity
sca
le, N
-PAS
S ne
ural
par
amet
ers
seve
rity
scal
e, O
FSS
orth
osta
tic fu
nctio
n se
verit
y sc
ale,
OPA
FSS
orth
osta
tic p
aram
eter
s fla
shba
cks
seve
rity
scal
e, O
PASS
orth
osta
tic
para
met
ers
seve
rity
scal
e, P
CL
ptsd
che
cklis
t, PC
L-C
pts
d ch
eckl
ist c
ivili
an v
ersi
on, P
DS
postt
raum
atic
stre
ss d
iagn
ostic
sca
le, P
SS p
hysi
cal s
ympt
om s
core
, PSS
-SR
phys
ical
sym
ptom
sco
re
self
repo
rt, P
TGI
postt
raum
atic
gro
wth
inve
ntor
y, P
TSD
pos
ttrau
mat
ic s
tress
dis
orde
r, SC
ID-5
stru
ctur
ed c
linic
al in
terv
iew
for
DSM
.5, S
CL-
90 s
ympt
om c
heck
list,
SDS
Shee
han
Dis
abili
ty
Scal
e, S
F so
cial
func
tioni
ng, S
F-M
PQ sh
ort-f
orm
McG
ill P
ain
Que
stion
naire
, SIT
stre
ss in
ocul
atio
n tra
inin
g, S
M st
ress
man
agem
ent,
SSI,
supp
lem
enta
l sec
urity
inco
me,
TAU
trea
tmen
t as u
sual
, TC
trau
ma
coun
selli
ng, T
F-C
BT tr
aum
a fo
cuse
d co
gniti
ve b
ehav
iour
al tr
eatm
ent,
TFT
Thou
ght F
ield
The
rapy
, TFT
trau
ma
foca
lized
trea
tmen
t, VA
S vi
sual
ana
logu
e sc
ale,
VC
OV
Che
cklis
t or
gani
zed
viol
ence
, WB-
FAC
ES-P
RS 5
, Won
g B
aker
face
s pai
n ra
ting
scal
e, W
HO
5 w
orld
hea
lth o
rgan
izat
ion
scal
e as
sess
men
t, W
HO
QO
L(5)
WH
O q
ualit
y of
life
, WLC
wai
ting
list c
ontro
l
1339Journal of Immigrant and Minority Health (2020) 22:1320–1346
1 3
Systematic Review
Qualitative analysis of the systematic review included 52 studies, 4 studies with control group, 21 studies with a fol-low up, 21 studies with both follow up and control group, 6 studies without control group and follow up.
Totally, in the 52 studies there were 4720 patients with a pre-treatment evaluation and 3913 with a pre and post treat-ment evaluations.
Eighty-eight trials, from the 52 studies, provided one of the following treatments: 22 trials performed the CBT (classic CBT treatments, eye movement desensitization reprocessing-EMDR, stress inoculation training-SIT, trauma counselling-TC, thought field therapy-TFT, exposition, stabi-lization, focalization, cognitive rebuilding-CR, self-manage-ment-SM), 9 trials performed the NET (wrote or no wrote), 15 trials performed the dynamic therapies (interpersonal psychotherapy-IPT, group facilitator for culture sensitive and resources oriented peer-CROP, Coffee and family education and support-CAFES, contact and safety planning-CSP, tea and family education and support-TAFES, satisfaction, tran-scendental meditation-TM, testimony psychotherapy-TP), 20 trials performed the combined cognitive psychological treat-ment and 23 trials performed the combined pharmacological and psychological treatments.
About legal status category, 31 studies reported refugee samples, 4 studies reported asylum seeker samples, 13 stud-ies reported both refugee and asylum seeker samples and 4 studies reported samples with not specified socio-politic status.
About provenance category, 20 studies treated Middle east populations, 8 studies treated African populations, 7 studies treated Asian populations, one study treated South American populations, 8 studies treated populations of dif-ferent provenience, 8 studies did not specify the provenance.
Mean number of sessions for each treatment category was respectively: CBT, 13 sessions of 81 min; NET, 7 ses-sions of 103 min; dynamic therapies, 22 sessions of 105 min; combined psychological treatments, 35 sessions of 59 min; combined psychological with pharmacological treatments, 18 sessions of 62 min.
In the systematic review each sample was considered and included in one, in two or in all the three outcomes (depres-sion, anxiety and somatization) considering the pre-post effect reported in each of the 52 studies resulting in one or two or three trials.
The systematic review included 52 studies for 107 sam-ples (139 trials). Of these 139 trials, 18 trials were excluded because of were not eligible treatments: 16 samples (16 trials) were usual treatments or wait lists and 2 samples (2 trials) were pharmacological treatments. The samples included in the final systematic review were 89 (121 trials). Qualitative results of the systematic review showed that the
CBT (22 samples with 28 trials) had significant effect on depression (18 trials) in 11/18 trials (61%) and no significant effect in 7/18 trials (39%). The CBT had significant effect on anxiety (8 trials) in 4/8 trials (50%) and no significant effects in 4/8 trials (50%). The CBT had significant effect on somatization (2 trials) in 0/2 (0%) trials and no significant effect in 2/2 trials (100%).
The NET (9 samples with 9 trails) had significant effects on depression in 4/7 trials (57%) and no significant effects in 3/7 trials (43%). There were not trials using NET on the anxiety outcome. The NET had significant effect on soma-tization in 1/2 trials (50%) and had not significant effects in 1/2 trials (50%).
The dynamic therapies (15 samples with 16 trials) had significant effect on depression in 5/10 trials (50%) and had no significant effect in 5/10 trials (50%). The dynamic thera-pies had significant effect on anxiety in 2/4 trials (50%) and had not significant effects in 2/4 trials (50%). The dynamic therapies had significant effect on somatization in 1/2 trials (50%) and had not significant effect in 1/2 trials (50%).
Combined psychological treatments (20 samples with 31 trials) had significant effect on depression in 6/13 trials (46%) and had not significant effect in 7/13 trials (54%). Combined psychological treatments had significant effect on anxiety in 6/13 trials (46%) and had not significant effect in 7/13 trials (54%). Combined psychological treatments had significant effect on somatization in 3/5 trials (60%) and had not significant effect in 2/5 trials (40%).
Combined psychological and pharmacological treatments (23 samples with 37 trials) had significant effect on depres-sion in 8/13 trials (61%) and not significant effect in 5/13 trials (39%). Combined psychological and pharmacologi-cal treatment had significant effect on anxiety in 4/11 trials (36%) and had not significant effect in 7/11 trials (64%). Combined psychological and pharmacological treatments had significant effect on somatization in 5/13 trials (39%) and had not significant effect in 8/13 trials (61%).
Metanalysis
Included Studies Characteristics and Outcome
Metanalysis included 27 studies for 75 trials.15 RCT, 4 of which presented a follow up, 2 showed
a control sample, and 9 reported a follow up and control sample.
4 MCT, one of which reported a control sample and 3 showed follow up and control sample.
8 SCT, 6 of which were planned with follow up, and 2 without a control sample and/or a follow up.
Depression outcome was treated in 26 studies (45 trials): 14 studies were RCT with 26 trials, 4 studies were MCT with 8 trials, and 8 studies were SCT with 11 trials.
1340 Journal of Immigrant and Minority Health (2020) 22:1320–1346
1 3
The anxiety outcome was treated in 14 studies (25 trials): 7 studies were RCT with 14 trials, 2 studies were MCT with 6 trials, and 5 studies were SCT with 5 trials.
The somatization outcome was treated in 3 RCT (5 trials).Moreover, regarding RCT, 6 studies assessed depression,
6 studies investigated depression and somatization, 1 study examined depression, anxiety and somatization, 1 study assessed depression and somatization, and 1 study con-sidered only somatization. With regard to MCT, 2 studies assessed depression and 2 studies examined depression and anxiety. As regard SCT, 5 studies investigated depression and anxiety and 3 studies considered depression.
As regard the treatment areas for RCT, 7 studies tested CBT treatments, 5 studies analyzed NET, 0 studies assessed dynamic therapies, 1 study investigated combined psycho-logical treatments, and 5 studies examined combined psy-chological and pharmacological treatments. About treatment area for MCT, 3 studies tested dynamic therapies, and 2 combined psychological treatments. About treatment area for SCT, 1 study assessed CBT treatment, 1 study analyzed NET, 0 studies investigated dynamic therapies, 4 studies examined combined psychological treatments, and 2 stud-ies explored combined psychological and pharmacological treatments.
Moreover, about the provenience area 11 RCT included Middle East populations and 3 studies tested populations from different provenances. About MCT, 3 studies tested Middle East populations, and one study Asian populations. About SCT, 2 studies included Middle East populations, 4 studies tested populations from different provenances, one study assessed African populations, and 2 studies did not specify the provenance of the participants.
Moreover, about the status area, 9 RCT investigated refu-gees, 2 studies included asylum seekers, 3 studies exam-ined both refugees and asylum seekers, and one study did not specify the status of the migrant participants. As regard MCT, 2 studies included refugees, and 2 studies consid-ered both refugees and asylum seekers. For SCT, 2 studies included refugees, one studies investigated asylum seekers, and 5 studies assessed both refugees and asylum seekers.
Participants of Metanalysis
The 27 selected studies involved the following number of participants (for all outcome): 956 participants pre-treatment and 774 participants post treatment as regard RCT design; 432 participants pre-treatment and 283 participants post treatment for MCT design; 809 participants pre-treatment and 785 participants post treatment regarding SCT design. The participants differentiated for outcome were: depres-sion 20,177 pre-treatment and 1822 post treatment; anxiety 1225 pre-treatment and 1086 post treatment; somatization 207 pre-treatment and 184 post treatment.
The participants were adult men and women, the age range was 19–51 years for RCT, 18–70 years for MCT, and 18–80 years for SCT.
Interventions Comparation of Metanalysis
The mean number of sessions was: 9.57 sessions of 98.7 min as regard RCT for CBT; 8.8 sessions of 96.6 min for NET; 10 sessions of 90 min for combined psychological treat-ments; 11.22 sessions of 70 min for combined pharmaco-logical and psychological treatments. As regard MCT there were found 60 sessions of 24 min for dynamic therapies and 71.5 sessions of 82.5 min for combined psychological treatments. With regard to SCT there were found 9.1 ses-sions of 60 min for CBT; 3 sessions for NET; 22 sessions of 23.25 min for combined psychological treatments; 47.75 sessions for combined pharmacological and psychological treatments.
Comparators
Comparators included the experimental samples and control samples if treated with CBT, NET, dynamic therapies with different manualization or combined psychological treat-ments and combined psychological and pharmacological treatments. There have been excluded the control samples as waiting lists.
Treatments Effects: Effect Size About Metanalysis
Metanalytic analysis was performed on 27 selected stud-ies separating the studies for outcome, depression, anxiety and somatization and for each different study design (RCT, MCT, and SCT). Successively, because of the high hetero-geneity, further sub-metanalysis have been performed fol-lowing the areas of interest (at least 4 trials were sufficient to perform a metanalysis): socio-politic status (asylum seek-ers and refugees), provenance, and treatment’s kind. The sub-metanalysis were performed considering the different outcomes and the different research designs.
Depression Outcome
3 main forest plots (7 forest plots, 2 funnel plots inside Sup-plementary Figures) have been obtained.
RCT-depression (Fig. 2): 936–754 participants pre-post treatment; Heterogeneity: Tau2 2.3, Chi2 803.72, df 25 (p < 0.00001), I2 97%; test for overall effect: Z 8.93 (p < 0.00001).
MCT-depression: 432–283 participants pre-post treat-ment; heterogeneity: Tau2 0.08, Chi2 25.02, df 7 (p = 0.0008), I2 72%; test for overall effect: Z 4.08 (p < 0.0001).
1341Journal of Immigrant and Minority Health (2020) 22:1320–1346
1 3
SCT-depression: 809–785 participants pre-post treatment; Heterogeneity: Tau2 0.56, Chi2 269.25, df 10 (p < 0.00001), I2 96%; test for overall effect: Z 6.45 (p < 0.00001).
Sub‑metanalysis Results on the Kind of Treatment for Depression RCT
CBT: 213–162 participants pre-post treatment (7 stud-ies—8 trial). Heterogeneity: Tau2 5.15; Chi2 230.88, df = 7, p < 0.00001; I2 97%; test for overall effect: Z 4.02 p = 0.0001.
NET: 138–114 participants pre-post treatment (5 stud-ies—5 trial). Heterogeneity: Tau2 23.22; Chi2 37.02 df = 4 p < 0.00001; I2 89%; test for overall effect: Z 2.4 p = 0.02.
Fig. 1 Flow chart selection and organization of the inclusion criteria and the studies for outcome (depression, anxiety, somatization) and research design (randomized controlled trial, multiple cohort trial, single cohort trial)
1342 Journal of Immigrant and Minority Health (2020) 22:1320–1346
1 3
Combined psychological and pharmacological treat-ments: 539–442 participants pre-post treatment (5 stud-ies—10 trial). Heterogeneity: Tau2 2.30; Chi2 444.14 df = 9 p < 0.00001; I2 98%; test for overall effect: Z 7.44 p < 0.00001.
Sub‑metanalysis Results on the Kind of Status for Depression RCT
Refugees: 714–585 participants pre-post treatment (8 studies—14 trial). Heterogeneity: Tau2 3.28; Chi2 640.06
Fig. 2 Forest plot that describes the difference pre and post intervention in the depression outcome. RCT research design
Fig. 3 Forest plot that describes the difference pre and post intervention in the anxiety outcome. RCT research design
1343Journal of Immigrant and Minority Health (2020) 22:1320–1346
1 3
df = 13 p < 0.00001; I2 98%; Test for overall effect: Z 9.34 p < 0.00001.
Asylum seekers: 87–80 participants pre-post treatment (3 studies—6 trial). Heterogeneity: Tau2 0.00; Chi2 3.99 df = 5 p < 0.55; I2 0%; test for overall effect: Z 2.36 p < 0.02.
Sub‑metanalysis Results for Kind of Status for Depression SCT
Refugees: 327–312 participants pre-post treatment (4 studies—5 trial). Heterogeneity: Tau2 1.40; Chi2 143.98 df = 4 p < 0.00001; I2 97%; Test for overall effect: Z 4.03 p < 0.0001.
Sub‑metanalysis Results on the Kind of Provenance for Depression RCT
Middle East: 837–662 participants pre-post treatment (11 studies—20 trial). Heterogeneity: Tau2 2.34; Chi2 654.76 df = 19 p < 0.00001; I2 97%; test for overall effect: Z 7.75 p < 0.00001.
Sub‑metanalysis Results for Kind of Treatment for Depression SCT
Combined psychological treatment: 313–295 participants pre-post treatment (4 studies—4 trial). Heterogeneity: Tau2 0.04; Chi2 15.59 df = 3 p = 0.001; I2 81%; Test for overall effect: Z 4.08 p < 0.0001.
Anxiety Outcome
RCT-anxiety (Fig. 3): 628–511 participants pre-post treatment; heterogeneity: Tau2 8.09, Chi2 1927.95 df 13 (p < 0.00001), I2 99%; test for overall effect: Z 2.24 (p = 0.03).
MCT-anxiety: 108 participants pre e post treatment; heterogeneity: Tau2 0.49, Chi2 91.99, df 5 (p < 0.00001), I2 95%; test for overall effect: Z 2.69 (p = 0.007).
SCT-anxiety: 489–467 participants pre-post treatment; heterogeneity: Tau2 0.06, Chi2 28.66 df 4 (p = 0.00001), I2 86%; test for overall effect Z 3.40 (p = 0.0007).
Sub‑metanalysis for Kind of Status on Anxiety RCT
Refugees: 605–488 participants pre-post treatment (5 stud-ies—11 trial). Heterogeneity: Tau2 9.31; Chi2 1813.09 df = 10 p < 0.00001; I2 99%; test for overall effect: Z 2.49 p = 0.01.
Sub‑metanalysis for Kind of Provenance on Anxiety RCT
Middle East: 558–443 participants pre-post treatment (4 studies—8 trial). Heterogeneity: Tau2 12.49; Chi2 1664.77 df = 7 p < 0.00001; I2 100%; test for overall effect: Z 1 p = 0.32.
Sub‑metanalysis for Kind of Treatment on Anxiety RCT
Combined psychological with pharmacological treatments: 535–436 participants pre-post treatment (5 studies—10 trial). Heterogeneity: Tau2 9.32; Chi2 1809.25 df = 9 p < 0.0001; I2 100%; test for overall effect: Z 2.69 p = 0.007.
Somatization Outcome
RCT-somatization (Fig. 4): 207–184 participants pre-post treatment. Heterogeneity: Tau2 0.02, Chi2 66.79, df 4 (p = 0.00001), I2 94%; test for overall effect: Z 2.13 (p = 0.03).
Methodological Quality: Publication Bias
The risk of bias among studies was high for many reasons, 13/27 (metanalysis) 30/52 (systematic review) publications were MCT and SCT studies this was the first issue hamper-ing the methodological quality of the studies. Moreover, in many studies the number of participants at the pre-treatment
Fig. 4 Forest plot that describes the difference pre and post intervention in the somatization outcome. RCT research design
1344 Journal of Immigrant and Minority Health (2020) 22:1320–1346
1 3
phase (T0) decreased in the post treatment (T1). Often treat-ments with the same approach were manualized in different ways. In some studies, the samples included both refugees and asylum seekers. The different status kind could have a different impact on the psychological health of the par-ticipants. Many studies did not have an appropriate random generation assignment sequence and did not report an occul-tation of the assignment sequence. Some trials coming from different studies, sometimes, used different instruments of measure to evaluate the same constructs.
Further, different types of bias were detected in the stud-ies selected for the present metanalysis and included: bias of data base, bias of inclusion, bias of language, and bias of effect size. Moreover, some studies did not report possible risks of bias. The summary of all biases and the high het-erogeneity were reported in two funnel plots. However, the two funnel plots showed a good symmetry.
Discussion
The main finding of the present metanalysis is that all treat-ments categories, and particularly the cognitive behavioural treatments, showed to be efficient on depression.
Moreover, the effect of the treatment was lower on the asylum seekers compared to the refugees.
Specifically, the cognitive behavioural treatments together combined psychological and pharmacological treatments seemed to be more efficacious on depression, even if in a lower number of studies.
The dynamic therapies showed a discrete efficacy trough observational methodological designs, there is a need of fur-ther investigation in this field due to the total lack of RCT.
As regard the migrant’s status (refugee or asylum seeker), the efficacy of the treatment on the depression showed a significant effect only for the status of refugee, whereas the effect was at the limit of significance with null degree of heterogeneity for the state of asylum seeker. This difference be could be due to adherence to the institutional expectation common in the asylum seekers applicants. In facts, they may have distorted the answers to the questionnaires in order to support or to influence the acceptation of their instance to receive an international protection [40]. This social desir-ability bias could modulate the pre-post evaluation dif-ferences or to attenuate the efficacy of the psychological intervention. This finding suggests to consider with great attention the variable of the status, and overall the pending instance condition of the migrant participants in the future studies. Considering that UNHCR data in Italy reported that in the first half of 2017 the total number of applications examined amounted to 41,379; only 4.3 out of 10 had a positive outcome (refugee status: 9%; subsidiary protection: 9.8%; permit for humanitarian reasons: 24.5%); for 51.7%
the exam ended with a denial, and 4.9% of the instances of the applicants were lost [41].
Other important results were that the psychological inter-ventions showed an effect on the mental health of migrants. The more evident effect of the psychological treatments was on the depression, despite the systematic review showed that only the 50% of the RCT found a significant difference between the pre and post evaluation. The specific metanaly-sis and sub-metanalysis showed high significance levels. For all the types of treatments with the exception of the narra-tive exposure therapies, that showed effects at the limit of significance. This finding suggest to conduct further experi-mental studies in order to confirm the efficacy of narrative exposure therapies on the depression outcome. Moreover the combined (psychological and pharmacological/psychologi-cal) treatments seem to show increased benefits compared to the single ones.
The metanalysis on depression in not randomized stud-ies (multiple and single perspective design studies) showed high levels of significance but with high levels of the heterogeneity.
Differently from the depression, the anxiety showed smaller effects of the psychological treatment. Not only the metanalysis showed decreased pre-post treatment effects on anxiety, but also the qualitative observation on the system-atic review showed a probability lower than 50% to have a significant pre-post treatment effects on trials with anxi-ety. Moreover, the number of the studies criteria allowed to perform only the metanalysis on the RCT studies with the combined psychological/pharmacological treatments where the effect was statistically significant. It seems necessary to plane further randomized studies in order to test the efficacy of specific psychological treatments on outcomes other than depression.
Moreover, the metanalysis performed only in middle-east migrant population showed a clear statistical pre-post effect of the psychological treatment on the depression out-come but not on the anxiety outcome. This result could be explained with the cultural characteristics of these popula-tions where the expression of the anxiety is under-repre-sented compared to other cultures [42].
Another important finding of the present study was that, at today, there are few studies on African and Asian popula-tions compared to the Middle East population. In the last years, a large entrance in Europe of the African popula-tion, as well as Syrian and Iranian population, has been observed. It seems to be necessary to increase the trials on the participants who have been involved in the current phe-nomena of migration as African, Asian, Syrian, and Iranian populations.
As regard the somatization outcome, the qualitative observation from the systematic review showed a probabil-ity of 42% to have a significant pre-post treatment effects on
1345Journal of Immigrant and Minority Health (2020) 22:1320–1346
1 3
randomized control, multiple and single perspective cohort trials of 42%. This limited qualitative evidence was con-firmed by the metanalyses on the RCT where the statistical effect was at the limit of significance. This finding suggests the need to conduct more studies focused on testing the effi-cacy of psychological treatments on somatization, talking into consideration of the population at today involved in the migration phenomena characterized by a culture where somatization could represent a privileged channel to express their psychological disease [43].
Moreover, the limited number of studies with outcome of anxiety and somatization did not allow to compare the effi-cacy of different types of psychological treatment on these outcomes revealing a hole in the literature that it is necessary fil up in the next future.
Future Research
For future developments, we suggest to extend the research to the outcome of psychological support for the migrants using a dynamic approach, possibly through RCT design. Moreover, it seems to necessary to confirm the efficacy of narrative exposure therapy on the depression increasing the studies number on this issue. According to this line, it could be interesting to turn the attention also to the expressive writing treatment of Pennebaker [44]. This treatment shows is more systematized procedure compared to the other nar-rative exposure therapies and it seems to demonstrate a good efficacy in brief times (3–5 days) adopting an exclusively written application modality. Nowadays, this type of treat-ment was not tested on migrants yet.
Finally, it would be useful increases the number of stud-ies of all psychological treatments applied on anxiety and somatization, possibly through RCT design.
Limitations
Few studies among those included in this systematic review treated the asylum seekers respect to the refugees.
Acknowledgements Open access funding provided by Università degli Studi di Roma La Sapienza within the CRUI-CARE Agreement.
Author Contributions DS drafted the protocol and with CL, PA, EB assessed the eligibility of the studies for inclusion, and extracted data. PA and DS developed the statistical code and performed the analyses. All authors contributed to the interpretation of the findings and to the drafting and editing of the manuscript.
Funding This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Compliance with Ethical Standards
Conflict of interest The authors declare that they have no competing interests.
Open Access This article is licensed under a Creative Commons Attri-bution 4.0 International License, which permits use, sharing, adapta-tion, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creat iveco mmons .org/licen ses/by/4.0/.
References
1. Lely JC, Smid GE, Jongedijk RA, Knipscheer W, Kleber RJ. The effectiveness of narrative exposure therapy: a review, meta-analysis and meta-regression analysis. Eur J Psychotraumatol. 2019;10:1550344.
2. Williams ME, Thompson SC. The use of community-based inter-ventions in reducing morbidity from the psychological impact of conflict-related trauma among refugee populations: a systematic review of the literature. J Immigr Minor Health. 2011;13:780–94.
3. Robjant K, Fazel M. The emerging evidence for narrative expo-sure therapy: a review. Clin Psychol Rev. 2010;30:1030–9.
4. Eurostat E: gas retail tables H1. European Comission; 2016 5. Tribe RH, Sendt KV, Tracy DK. A systematic review of psychoso-
cial interventions for adult refugees and asylum seekers. J Mental Health. 2019;28:662–76.
6. UNHCR W UNAIDS. Policy statement on HIV testing and coun-selling in health facilities for refugees, internally displaced per-sons and other persons of concern to UNHCR. Geneva; 2014.
7. Unhcr R. Syria regional refugee response. Turkey: UNHCR Inter-agency Information Sharing Portal; 2016.
8. Gwozdziewycz N, Mehl-Madrona L. Meta-analysis of the use of narrative exposure therapy for the effects of trauma among refugee populations. Perm J. 2013;17:70.
9. Mahoney A, Karatzias T, Hutton P. A systematic review and meta-analysis of group treatments for adults with symptoms associ-ated with complex post-traumatic stress disorder. J Affect Disord. 2019;243:305–21.
10. Pompili M, Gibiino S, Innamorati M, Serafini G, Del Casale A, De Risio L, Sher L. Prolactin and thyroid hormone levels are associ-ated with suicide attempts in psychiatric patients. Psychiatry Res. 2012;200(2–3):389–94.
11. Pompili M, Shrivastava A, Serafini G, Innamorati M, Milelli M, Erbuto D, Lester D. Bereavement after the suicide of a significant other. Indian J Psychiatry. 2013;55(3):256.
12. Slobodin O, de Jong JT. Family interventions in traumatized immigrants and refugees: a systematic review. Transcult Psychia-try. 2015;52:723–42.
13. Acarturk C, Konuk E, Cetinkaya M, Senay I, Sijbrandij M, Cui-jpers P, Aker T. EMDR for Syrian refugees with posttraumatic stress disorder symptoms: results of a pilot randomized controlled trial. Eur J Psychotraumatol. 2015;6:27414.
14. Acarturk C, Konuk E, Cetinkaya M, Senay I, Sijbrandij M, Gulen B, Cuijpers P. The efficacy of eye movement desensitization and reprocessing for post-traumatic stress disorder and depression
1346 Journal of Immigrant and Minority Health (2020) 22:1320–1346
1 3
among Syrian refugees: results of a randomized controlled trial. Psychol Med. 2016;46:2583–93.
15. Adenauer H, Catani C, Gola H, Keil J, Ruf M, Schauer M, Neuner F. Narrative exposure therapy for PTSD increases top-down pro-cessing of aversive stimuli-evidence from a randomized controlled treatment trial. BMC Neurosci. 2011;12:127.
16. Buhmann CB, Nordentoft M, Ekstroem M, Carlsson J, Mortensen EL. The effect of flexible cognitive–behavioural therapy and med-ical treatment, including antidepressants on post-traumatic stress disorder and depression in traumatized refugees: pragmatic rand-omized controlled clinical trial. Br J Psychiatry. 2016;208:252–9.
17. Carlsson J, Sonne C, Vindbjerg E, Mortensen EL. Stress manage-ment versus cognitive restructuring in trauma-affected refugees: a pragmatic randomized study. Psychiatry Rec. 2018;266:116–23.
18. Hensel-Dittmann D, Schauer M, Ruf M, Catani C, Odenwald M, Elbert T, Neuner F. Treatment of traumatized victims of war and torture: a randomized controlled comparison of narrative exposure therapy and stress inoculation training. Psychother Psychosom. 2011;80:345–52.
19. Hijazi AM, Lumley MA, Ziadni MS, Haddad L, Rapport LJ, Arnetz BB. Brief narrative exposure therapy for posttraumatic stress in Iraqi refugees: a preliminary randomized clinical trial. J Trauma Stress. 2014;27:314–22.
20. Hinton DE, Pham T, Tran M, Safren SA, Otto MW, Pollack MH. CBT for Vietnamese refugees with treatment-resistant PTSD and panic attacks: a pilot study. J Trauma Stress. 2004;17:429–33.
21. Hinton DE, Chhean D, Pich V, Safren SA, Hofmann SG, Pollack MH. A randomized controlled trial of cognitive-behavior therapy for Cambodian refugees with treatment-resistant PTSD and panic attacks: a cross-over design. J Trauma Stress. 2005;18:617–29.
22. Neuner F, Kurreck S, Ruf M, Odenwald M, Elbert T, Schauer M. Can asylum-seekers with posttraumatic stress disorder be success-fully treated? A randomized controlled pilot study. Cogn Behav Therapy. 2010;39:81–91.
23. Paunovic N, Öst LG. Cognitive-behavior therapy vs exposure therapy in the treatment of PTSD in refugees. Behav Res Ther. 2001;39:1183–97.
24. Sonne C, Carlsson J, Bech P, Vindbjerg E, Mortensen EL, Elk-lit A. Psychosocial predictors of treatment outcome for trauma-affected refugees. Eur J Psychotraumatol. 2016;7:30907.
25. Stenmark H, Catani C, Neuner F, Elbert T, Holen A. Treating PTSD in refugees and asylum seekers within the general health care system. A randomized controlled multicenter study. Behav Res Ther. 2013;51:641–7.
26. ter Heide FJJ, Mooren T, Kleijn W, de Jongh A, Kleber R. EMDR versus stabilisation in traumatised asylum seekers and refugees: results of a pilot study. Eur J Psychotraumatol. 2011;2:5881.
27. Wang SJ, Bytyçi A, Izeti S, Kallaba M, Rushiti F, Montgomery E, Modvig J. A novel bio-psycho-social approach for rehabilita-tion of traumatized victims of torture and war in the post-conflict context: a pilot randomized controlled trial in Kosovo. Conflict Health. 2017;10:34.
28. Drožđek B, Bolwerk N. Evaluation of group therapy with trauma-tized asylum seekers and refugees: the Den Bosch Model. Trau-matology. 2010;16:117–27.
29. Droždek B, Kamperman AM, Bolwerk N, Tol WA, Kleber RJ. Group therapy with male asylum seekers and refugees with posttraumatic stress disorder: a controlled comparison cohort
study of three day-treatment programs. J Nerv Ment Dis. 2012;200(9):758–65.
30. Lakshimi Vijayakumar L. Challenges and opportunities in suicide prevention in South-East Asia. WHO South-East Asia J Public Health. 2017;6:45–9.
31. Weinstein N, Khabbaz F, Legate N. Enhancing need satisfaction to reduce psychological distress in Syrian refugees. J Consult Clin Psychol. 2016;84:645.
32. Brune M, José Eiroá-Orosa F, Fischer-Ortman J, Haasen C. Effectiveness of psychotherapy for traumatized refugees with-out a secure residency status. Intl J Migrat Health Social Care. 2014;10:52–9.
33. Carlsson JM, Olsen DR, Kastrup M, Mortensen EL. Late mental health changes in tortured refugees in multidisciplinary treatment. J Nerv Ment Dis. 2010;198:824–8.
34. d’Ardenne P, Ruaro L, Cestari L, Fakhoury W, Priebe S. Does interpreter-mediated CBT with traumatized refugee people work? A comparison of patient outcomes in East London. Behav Cogn Psychother. 2007;35:293–301.
35. Drožđek B, Kamperman AM, Tol WA, Knipscheer JW, Kleber RJ. Seven-year follow-up study of symptoms in asylum seekers and refugees with PTSD treated with trauma-focused groups. J Clin Psychol. 2014;70:376–87.
36. Halvorsen JØ, Stenmark H. Narrative exposure therapy for post-traumatic stress disorder in tortured refugees: a preliminary uncontrolled trial. Scand J Psychol. 2010;51:495–502.
37. Raghavan S, Rasmussen A, Rosenfeld B, Keller AS. Correlates of symptom reduction in treatment-seeking survivors of torture. Psychol Trauma. 2013;5:377.
38. Sierre van Wyk S, Schweitzer R, Brough M, Vromans L, Murray K. A longitudinal study of mental health in refugees from Burma: the impact of therapeutic interventions. Aust N Z J Psychiatry. 2012;46:995–1003.
39. Whitsett D, Sherman MF. Do resettlement variables predict psy-chiatric treatment outcomes in a sample of asylum-seeking sur-vivors of torture? Int J Soc Psychiatry. 2017;63:674–85.
40. Heeren M, Wittmann L, Ehlert U, Schnyder U, Maier T, Müller J. Psychopathology and resident status: comparing asylum seekers, refugees, illegal migrants, labor migrants, and residents. Compr Psychiatry. 2014;55(4):818–25.
41. Fondazione I. S. M. U. Ventitreesimo Rapporto sulle migrazioni 2017; Franco Angeli; 2017.
42. Norton PJ. Depression Anxiety and Stress Scales (DASS-21): psychometric analysis across four racial groups. Anxiety Stress Coping. 2007;20:253–65.
43. Rohlof HG, Knipscheer JW, Kleber RJ. Somatization in refugees: a review. Soc Psychiatry Psychiatr Epidemiol. 2014;49:1793–804.
44. Pennebaker JW, Evans JF. Expressive writing: words that heal: using expressive writing to overcome traumas and emotional upheavals, resolve issues, improve health, and build resilience. Enumclaw: Idyll Arbor; 2014.
Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.